First Thomas Pickering memorial lecture: Ambulatory blood pressure measurement is essential for the management of hypertension

Journal of Clinical Hypertension

Volumn 14, Issue 12, 2012, Pages 836-847

  O'Brien, Eoin ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; METOPROLOL; PINDOLOL; PROPRANOLOL;

ARTICLE; BLOOD PRESSURE MONITORING; BORDERLINE HYPERTENSION; CIRCADIAN RHYTHM; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH CARE PERSONNEL; HUMAN; HYPERTENSION; MASKED HYPERTENSION; MORNING DOSAGE; NOCTURNAL HYPERTENSION; NON INVASIVE PROCEDURE; PHARMACIST; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTER; RISK FACTOR; UNITED STATES; WHITE COAT HYPERTENSION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; BLOOD PRESSURE MONITORS; DISEASE MANAGEMENT; DRUG CHRONOTHERAPY; DRUG MONITORING; HISTORY, 20TH CENTURY; HUMANS; MASKED HYPERTENSION; WHITE COAT HYPERTENSION;

EID: 84870482151     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2012.00698.x     Document Type: Article

References (80)

1. White WB. In memoriam. Thomas G. Pickering 1940-2009. Hypertension. 2009;54:917-918.
2. O'Brien E. In memoriam. J Hypertens. 2009;27:1715-1716.
3. O'Brien E, White W. Thomas G. Pickering: friend, colleague and scientist. Blood Press Monit. 2010;15:67-69.
4. O'Brien E, Fitzgerald D The history of indirect blood pressure measurement. In: O'Brien E, O'Malley K, eds. Blood Pressure Measurement. Handbook of Hypertension. Eds. W.H. Birkenhager and J.L. Reid. Amsterdam: Elsevier; 1991:1-54.
5. Bevan AI, Honour AT, Stott FH. Direct arterial pressure recording in unrestricted man. Clin Sci. 1969;36:329-344.
6. Mann S, MilIar Craig MW, Balasubramaniam V, et al. Ambulant blood pressure; reproducibility and the assessment of interventions. Clin Sci. 1980;59:497-500.
7. Millar Craig MW, Kenny D, Mann S, et al. Effect of once-daily atenolol on ambulatory blood pressure. BMJ. 1979;i:237-238.
8. Floras JS, Jones JV, Hassan MO, Sleight P. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol. BMJ. 1982;285:1387-1392.
9. O'Brien E. The value of 24-hour blood pressure monitoring to assess the efficacy of antihypertensive drug treatment. Hot Topics in Hypertens. 2011;4:7-23.
10. Kain HK, Hinman AT, Sokolow M. Arterial blood pressure measurements with a portable recorder in hypertensive patients. I. Variability and correlation with casual pressures. Circulation. 1964;30:882-892.
11. Fitzgerald DJ, O'Callaghan WO, McQuaid R, O'Malley K, O'Brien E. Accuracy and reliability of two indirect ambulatory blood pressure recorders: Remler M2000 and Cardiodyne Sphygmolog. Br Heart J. 1982;48:572-579.
12. O'Brien E, Cox J, O'Malley K. Ambulatory blood pressure measurement in the evaluation of blood pressure lowering drugs. J Hypertens. 1989;7:243-247.
13. Garret BN, Kaplan N. Ambulatory blood pressure monitoring: a question of now and the future. J Clin Hypertens. 1987;3:378-380.
14. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA. 1983;249:2792-2798.
15. Pickering TG, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension. 2002;40:795-796.
16. Gerin W, James GD. Psychosocial determinants of hypertension: laboratory and field models. Blood Press Monit. 2012;15:93-99.
17. Parati G, Krakoff LR, Verdecchia P. Methods of measurements: home and ambulatory blood pressure monitoring. Blood Press Monit. 2012;15:100-105.
18. Pickering TG, Houston Miller N, Ogedegbe G, et al. Call to action on use and reimbursement for home blood pressure monitoring. A joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52:10-29.
19. Pickering TG, James GD, Boddie C, et al. How common is white coat hypertension? JAMA. 1988;259:225-228.
20. Staessen JA, Byttebier G, Buntinx F, et al. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. JAMA. 1997;278:1065-1072.
21. Banegas JR, Segura J, Sobrino J, et al. Effectiveness of blood pressure control outside the medical setting. Hypertension. 2007;49:62-68.
22. Mancia G. Reversed white-coat hypertension: definition, mechanisms and prognostic implications. J Hypertens. 2002;20:579-581.
23. Wing LMH, Brown MA, Beilin LJ, et al. 'Reverse white-coat hypertension' in older hypertensives. J Hypertens. 2002;20:639-644.
24. Ogedegbe G. Causal mechanisms of masked hypertension: socio-psychological aspects. Blood Press Monit. 2012;15:90-92.
25. Liu JE, Roman MJ, Pini R, et al. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med. 1999;131:564-572.
26. Ungar A, Pepe G, Monami M, et al. Isolated ambulatory hypertension is common in outpatients referred to a hypertension center. J Hum Hypertens. 2004;18:897-903.
27. Palatini P, Winnicki M, Santonastaso M, et al. Prevalence and clinical significance of isolated ambulatory hypertension in young subjects screened for stage 1 hypertension. Hypertension. 2004;44:170-174.
28. O'Brien E. Unmasking hypertension. Hypertension. 2005;45:481-482.
29. Lurbe E, Torro I, Alvarez V, et al. Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension. 2005;45:493-498.
30. O'Brien E, Sheridan J, O'Malley K. Dippers and non-dippers. Lancet. 1988;ii:397.
31. Stolarz-Skrzypek K, Thijs L, Richart T, et al. From pioneering to implementing automated Blood Pressure measurement in clinical practice: Thomas Pickering's legacy. Blood Press Monit. 2010;15:72-81.
32. Pickering TG, Harshfield GA, Kleinert HD, et al. Blood pressure during normal daily activities, sleep, and exercise. Comparison of values in normal and hypertensive subjects. JAMA. 1982;247:992-996.
33. Boggia J, Li Y, Thijs L, et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370:1219-1229.
34. O'Brien E. 24-hour ambulatory blood pressure measurement in clinical practice and research: a critical review of a technique in need of implementation. J Intern Med. 2011;269:478-495.
35. Kario K. Thomas G. Pickering - a great mentor. Blood Press Monit. 2012;15:82-84.
36. Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as predictor of silent and clinical cerebrovascular disease in elderly hypertensives. A prospective study. Circulation. 2003;107:1401-1406.
37. Li Y, Thijs L, Hansen TW, et al. Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations. Hypertension. 2010;55:1040-1048.
38. Israel S, Israel A, Ben-Dov IZ, Bursztyn M. The morning blood pressure surge and all-cause mortality in patients referred for ambulatory blood pressure monitoring. Am J Hypertens. 2011;24:796-801.
39. Pickering TG. A review of national guidelines on the clinical use of ambulatory blood pressure monitoring. Blood Press Monit. 1996;1:151-156.
40. National Institute for Health and Clinical Excellence (NICE). Hypertension. The clinical management of primary hypertension in adults. Clinical Guideline 127. 2011. http://www.nice.org.uk/guidance/CG127.
41. Pickering TG, Shimbo D, Haas D. Ambulatory blood pressure monitoring. N Engl J Med. 2006;354:2368-2374.
42. O'Brien E, Coats A, Owens P, et al. Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British Hypertension Society. BMJ. 2000;320:1128-1134.
43. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. US Department of Health and Human Services. National Institutes of Health National Heart, Lung, and Blood Institute National High Blood Pressure Education Program. NIH Publication No. 04-5230, August 2004.
44. O'Brien E, Asmar R, Beilin L, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens. 2003;21:821-848.
45. Williams B, Poulter NR, Brown MJ, et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens. 2004;18:139-185.
46. Pickering TG, Hall JE, Appel LA, et al. Recommendations for blood pressure measurement in humans and experimental animals part 1: blood pressure measurement in humans a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005;45:142-161.
47. Guideline For Ambulatory Blood Pressure Monitoring. Guideline for home blood pressure. Monitoringarquivos Brasileiros De Cardiologia. 2005;85(suppl Ii):1-18.
48. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105-1187.
49. Italian Society of Hypertension (SIIA). Guidelines for conventional and automated blood pressure measurement in the office, at home and over the 24hours. Guideline http://www.pressionearteriosa.net/documents/common/Library-Lineeguida-Siia-Misurazione-Pressione-Eng.pdf. Accessed July 25, 2012.
50. 2011 Canadian Hypertension Education Program (CHEP) Recommendations for the Management of Hypertension. http://www.hypertension.ca/images/stories/dls/2011gl/FullCHEPRecommendations_EN_2011.pdf. Accessed July 25, 2012.
51. Seedat YK, Rayner BL. South African Hypertension Guideline 2011. S Afr Med J. 2012;102:57-84.
52. Guidelines for the clinical use of 24hour ambulatory blood pressure monitoring (Japanese circulation society). Circ J. 2012;76:508-519 http://www.j-circ.or.jp/guideline/pdf/JCS2010_shimada_d.pdf. Accessed July 25, 2012.
53. Head GA, McGrath BP, Mihailidou AS, et al. Ambulatory blood pressure monitoring in Australia: 2011 consensus position statement. J Hypertens. 2012;30:253-266.
54. Verdecchia P, O'Brien E, Pickering T, et al. When to suspect white coat hypertension? Statement from the Working Group on Blood Pressure Monitoring of the European Society of Hypertension. Am J Hypertens. 2003;16:87-91.
55. O'Brien E. History of the blood pressure unit at the charitable infirmary and Beaumont Hospital 1978-2006. Heartwise. Winter 2006. 12-18. Available at: http://www.eoinobrien.org/wp-content/uploads/2007/07/history-of-bpuheartwise2006.pdf. Accessed July 25, 2012.
56. O'Brien E. Overdiagnosing hypertension. BMJ. 1988;297:1211-1212.
57. O'Brien E, Atkins N. Can improved software facilitate the wider use of ambulatory blood pressure measurement in clinical practice? Blood Press Monit. 2004;9:237-241.
58. McGowan N, Atkins N, O'Brien E, Padfield P. Computerised reporting improves the clinical use of ambulatory blood pressure measurement. Blood Press Monit. 2010;15:115-123.
59. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006;296:2563-2571.
60. Weber CA, Ernst ME, Sezate GS, et al. Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures. Arch Intern Med. 2010;170:1634-1639.
61. Sendra-Lillo J, Sabater-Hernandez D, Sendra-Ortola A, Martinez-Martinez F. Agreement between community pharmacy, physician's office, and home blood pressure measurement methods: the Palmera study. Am J Hypertens. 2012;25:290-296.
62. Carter BL, Foppe van Mil JW. Comparative effectiveness research: evaluating pharmacist interventions and strategies to improve medication adherence. Am J Hypertens. 2010;23:949-955.
63. Heisler M, Hofer TP, Schmittdiel JA, et al. Improving blood pressure control through a clinical pharmacist outreach program in diabetes patients in two-high performing health systems: the adherence and intensification of medications (AIM) cluster randomized controlled pragmatic trial. Circulation. 2012; http://circ.ahajournals.org/content/early/2012/05/08/CIRCULATIONAHA.111.089169. Accessed July 25, 2012.
64. Pickering T, Schwartz J, Verdecchia P, et al. An international database of prospective ambulatory blood pressure monitoring studies. Blood Press Monit. 2003;8:147-149.
65. Schwartz JE, Verdecchia P, Pickering TG, et al. Ambulatory and clinic BP as predictors of stroke incidence and CV mortality: analysis of studies from Italy, Japan and USA (abstract). Circulation. 2002;106:ii-759.
66. Gliklich RE, Dreyer NA, eds. Registries for Evaluating Patient Outcomes: A User's Guide, 2nd edn. (Prepared by Outcome DEcIDE Center [Outcome Sciences, Inc. d/b/a Outcome] under Contract No. HHSA29020050035I TO3.) AHRQ Publication No. 10-EHC049. Rockville, MD: Agency for Healthcare Research and Quality; 2010.
67. Kennedy L, Craig AM. Global registries for measuring pharmacoeconomic and quality-of-life outcomes: focus on design and data collection, analysis and interpretation. Pharmacoeconomics. 2004;22:551-568.
68. Dhruva SS, Phurrough SE, Salive ME, Redberg RF CMS's landmark decision on CT colonography - examining the relevant data. N Engl J Med. 2009;360:2699-2701.
69. Postmarketing studies and clinical trials - implementation of Section 505(o) of the Federal Food, Drug and Cosmetic Act. FDA Guidance for Industry. Draft guidance. July 2009.
70. van Onzenoort HAW, Menger FE, Neef C, et al. Participation in a clinical trial enhances adherence and persistence to treatment: a retrospective cohort study. Hypertension. 2011;58:573-578.
71. Editorial. Lancet 2011;378:50.
72. Larsson S, Lawyer P, Garellick G, et al. Use of 13 disease registries in 5 countries demonstrates the potential to use outcome data to improve health care's value. Health Aff. Available at: http://content.healthaffairs.org/content/early/2011/12/06/hlthaff.2011.0762. Accessed July 25, 2012.
73. Dolan E, Stanton A, Thijs L, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 2005;46:156-161.
74. Gorostidi M, Sobrino J, Segura J, et al. Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20, 000-patient database in Spain. J Hypertens. 2007;25:977-984.
75. Boggia J, Li Y, Thijs L, et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370:1212-1219.
76. Parati G, Omboni S, Stergiou G, et al. Geographical features and determinants of masked hypertension in 9, 753 hypertensive subjects from five continents: the Artemis International Registry. J Hypertens. 2012;30(e-suppl):e1-e2.
77. Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123:933-944.
78. The Guide to Community Preventive Service. Centers for Disease Control and Prevention. Atlanta, GA Available at: http://www.cdc.gov/24-7/prevention/MillionHearts/. Accessed July 25, 2012.
79. Million Hearts initiative. Available at: http://millionhearts.hhs.gov/. Accessed July 25, 2012.
80. New US target to prevent 1 million heart attacks and strokes. Lancet. 2011;378:1118.